Defect in dimethylglycine dehydrogenase, a new inborn error of metabolism: NMR spectroscopy study.

BACKGROUND A38-year-old man presented with a history of fish odor (since age 5) and unusual muscle fatigue with increased serum creatine kinase. Our aim was to identify the metabolic error in this new condition. METHODS We used 1H NMR spectroscopy to study serum and urine from the patient. RESULTS The concentration of N, N-dimethylglycine (DMG) was increased approximately 100-fold in the serum and approximately 20-fold in the urine. The presence of DMG as a storage product was confirmed by use of 13C NMR spectroscopy and gas chromatography-mass spectrometry. The high concentration of DMG was caused by a deficiency of the enzyme dimethylglycine dehydrogenase (DMGDH). A homozygous missense mutation was found in the DMGDH gene of the patient. CONCLUSIONS DMGDH deficiency must be added to the differential diagnosis of patients complaining of a fish odor. This deficiency is the first inborn error of metabolism discovered by use of in vitro 1H NMR spectroscopy of body fluids.

[1]  J. Lindon,et al.  Uroscopy in the 21st century: high-field NMR spectroscopy. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  L. Barness.  The metabolic and molecular bases of inherited disease, 7th ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, Vol. 3, McGraw Hill, New York, 1995, pp. 4605. , 1996 .

[3]  T. Cox.  The metabolic and molecular bases of inherited disease: Vols I, II and III (7th edn): edited by Charles R. Scriver, Arthur L. Beaudet, William S. Sly and David Valle McGraw-Hill, 1995, £195.00 hbk (4605 pages) ISBN 0 07 909826 6 , 1996 .

[4]  R. Chalmers,et al.  High-resolution 1H-NMR spectroscopy of blood plasma for metabolic studies. , 1995, Clinical chemistry.

[5]  A Heerschap,et al.  Standardized method for high-resolution 1H-NMR of cerebrospinal fluid. , 1995, Clinical chemistry.

[6]  P. Lundberg,et al.  1H NMR determination of urinary betaine in patients with premature vascular disease and mild homocysteinemia. , 1995, Clinical chemistry.

[7]  L. Taylor.  Disordered methionine/homocysteine metabolism in premature vascular disease: Dudman NPB, Wilcken DEL, Wang J, Lynch JF, Macey D, Lundberg P. Arterioscler Thromb 1993;13:1253-60 , 1994 .

[8]  G Helms,et al.  Creatine Deficiency in the Brain: A New, Treatable Inborn Error of Metabolism , 1994, Pediatric Research.

[9]  R. Allen,et al.  Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism. , 1993, Metabolism: clinical and experimental.

[10]  P. Lundberg,et al.  Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[11]  J. Leonard,et al.  Investigation of urea cycle enzyme disorders by 1H-NMR spectroscopy. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[12]  K. Hammond,et al.  TRIMETHYLAMINURIA: THE FISH-ODOUR SYNDROME , 1970 .

[13]  Mackenzie Cg,et al.  Production of active formaldehyde in the mitochondrial oxidation of sarcosine-CD3. , 1956 .